Glaxo Settles Illegal Marketing Claims for $3 Billion
The British drug-maker GlaxoSmithKline agreed to pay $3 billion to settle claims related to illegal marketing of drugs. The U.S. government’s civil and criminal investigations of Glaxo related to multiple different drugs. The settlement includes resolution of allegations that Glaxo improperly marketed the drug Avandia, a drug whose use was severely restricted after studies indicated it is linked to heart risks. The $3 billion settlement to resolve criminal and civil investigations represents the largest such settlement ever reached, surpassing the $2.3 billion paid by Pfizer last year.
The claims against Glaxo are representative of numerous claims against drug companies. Settlements with pharmaceutical companies represented roughly 80 percent of the $4 billion in overcharges the federal government recovered in 2010.
Read the New York Times story.
Share This“Thank you so much for everything that you did for Gene and I in our lawsuit and trial. We appreciate all of the hard work, long hours and care that was shown to us. All of you are such special people to us. We are so fortunate to have been represented by the five of you. I hope that you got the chance to get some well deserved rest and sleep. Thanks again for everything. Sincerely…”
Contact Our North Carolina Personal Injury Law Firm
for a Consultation for Your Accident or Medical Malpractice Claim
The law firm you choose makes a difference. If you are the victim of an accident or an illness that someone else caused, the North Carolina personal injury law firm of Martin & Jones has the depth of experience, skills and sensitivity to make your road to recovery as smooth as possible. Whether you have experience with the legal system or have never hired a medical malpractice or personal injury lawyer before, our attorneys and staff will do our best to answer your questions, provide clear advice and prepare you and your family for what to expect. If you would like more information or to meet with one of our attorneys, please fill out the form below or call us at 800.662.1234.